Skip to main content
Erschienen in: World Journal of Surgical Oncology 1/2014

Open Access 01.12.2014 | Research

Liver resection for young patients with large hepatocellular carcinoma: a single center experience from China

verfasst von: Xi-yu Liu, Jiang-feng Xu

Erschienen in: World Journal of Surgical Oncology | Ausgabe 1/2014

Abstract

Background

To investigate retrospectively the clinicopathological characteristics and outcomes of young patients with large hepatocellular carcinoma after hepatectomy.

Methods

From January 2003 to December 2012, a total of 153 patients with large hepatocellular carcinoma (HCC) who received liver resection were included in the study. The clinicopathological features were analyzed retrospectively. The perioperative data were compared between those aged <40 years (the young group) and those aged >40 years (the older group). Prognostic factors and long-term survival were evaluated.

Results

The young group had more hepatitis B virus-related HCC than the older group (87.2% vs 66.3%, P = 0.031). In the young group, 15 patients (21.5%) were overweight (body mass index 25 to 29.9 kg/m2) or obese (body mass index ≥30 kg/m2), and 38 patients (45.8%) were overweight or obese in the older group (P = 0.032). Other clinicopathological characteristics were similar between the two groups. The perioperative data showed that the older group had more pulmonary infection after hepatectomy. Vascular invasion and high Edmondson-Steiner grade were the independent prognostic factors for long-term survival. There was no statistical difference between the young group and the older group in overall survival and disease-free survival (P = 0.109 and P = 0.087, respectively).

Conclusions

Liver resection for young patients with large HCC was safe and efficacious and should be recommended.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1477-7819-12-175) contains supplementary material, which is available to authorized users.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

XYL and JFX carried out the data collection and analysis, drafted the manuscript. Both authors read and approved the final manuscript.
Abkürzungen
AFP
alpha-fetoprotein
BMI
body mass index
HBV
hepatitis B virus
HCC
hepatocellular carcinoma.

Background

Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide, especially in China. HCC ranks second as a cause of cancer death overall in China[14]. Many studies have reported that hepatectomy could be performed satisfactorily for large HCC (>5 cm) with acceptable mortality[57]. However, there are few reports about the clinicopathological features and outcomes in young patients with large HCC after hepatectomy, and the significance of hepatectomy for these patients therefore remains unknown.
In USA and Europe, which are not hepatitis B endemic areas, patients younger than 40 years of age with large HCC are reported to be rare;however, young patients with large HCC are not uncommon in China. To investigate the clinicopathological features as well as the long-term outcomes after hepatectomy of young patients with large HCC, we performed a retrospective study of patients with large HCC undergoing hepatectomy whose ages were younger than 40 years (the young group), compared to those patients aged above 40 years (the older group).

Methods

From January 2003 to December 2012, 153 patients with large HCC (>5 cm) were treated surgically in the Affiliated Hospital of Zhejiang University School of Medicine. Patients younger than 40 years of age (n = 70) were defined as the young group And patients aged above 40 years (n = 83) were defined as the older group. Preoperative evaluation protocol included blood biochemistry, chest radiography, liver and renal function tests, ultrasonography, contrast computed tomography and indocyanine green clearance test.
Liver resection was undertaken in the patients with good cardiopulmonary and renal function, Pugh–Child’s grades A and B, and indocyanine green test at 15 min <15%.
All intraoperative and postoperative complications were reviewed retrospectively through medical records. Complications (Clavien-Dindo gradesI-V) contained ascites, wound infection, pleural effusion, pulmonary infection, biliary fistula, liver failure and bleeding. Follow-up data were obtained by direct communication with patients after they underwent hepatic resection. All patients were examined for recurrence by clinical examination, alpha-fetoprotein (AFP) and ultrasonography. The follow-up period was calculated from the date of surgery to the date of either death or last follow-up. Prior informed consent was obtained from all patients and the study was approved by the Ethics Committee of Yiwu affiliated hospital of zhejiang university school of medicine.
Continuous variables were expressed as mean ± SD and compared using the independent-samples t test. Categorical data analysis used the rank test or chi-square test. Survival analysis, including overall survival and disease-free survival, was estimated by the Kaplan-Meier survival method and compared using the log-rank test. Univariate and multivariate analysis by the Cox proportional hazard regression model was used to identify independent prognostic factors. All statistical analyses were performed using statistical software (SPSS 13.0 for Windows;SPSS, Chicago, IL, USA). P < 0.05 was considered to be statistically significant.

Results

Clinicopathologic features of patients with large hepatocellular carcinoma

The clinicopathologic parameters of the 153 patients with large HCC who underwent liver resection are shown in Table 1. The age of the young group was 32 ± 5 years compared to 55 ± 9 years in the older group. In the young group, 61 patients (87.2%) had positive hepatitis B in serologic test results; however, only 55 patients (66.3%) had positive hepatitis B in the older group. In the young group, 15 patients (21.4%) were overweight (body mass index (BMI) 25 to 29.9 kg/m2) or obese (BMI ≥30 kg/m2), and 38 patients (45.8%) were overweight or obese in the older group (P = 0.032). Clinicopathologic characteristics, including size of tumor, vascular invasion, tumor number, capsular formation, AFP level, liver cirrhosis, and Child-Pugh classification, showed no statistical difference between two groups.
Table 1
Clinicopathologic features of 153 patients with large hepatocellular carcinoma
Variables
Mean ± SD or number (%) of patients
Young group (n = 70)
Older group (n = 83)
P value
Gender
   
 Female
17 (24.2%)
11(13.3%)
0.196
 Male
53 (75.8%)
72(86.7%)
Age (years)
32 ± 5
55 ± 9
<0.001
Hepatitis B status
   
 Negative
9 (12.8%)
28(33.7%)
0.031
 Positive
61 (87.2%)
55(66.3%)
Capsular formation
   
 Presence
32 (45.7%)
29(34.9%)
0.535
 Absence
38 (54.3%)
54(65.1%)
Tumor number
   
 Single
49(70.0%)
60(72.3%)
0.654
 Multiple
21(30.0%)
23(27.7%)
AFP level
   
 Negative
21 (30.0%)
32(38.5%)
0.616
 Positive
49 (70.0%)
51(61.5%)
Liver cirrhosis
   
 Absent
38 (54.3%)
44(53.0%)
0.851
 Present
32 (45.7%)
39(47.0%)
Child-Pugh classification
   
 A
56 (80.0%)
73(87.9%)
0.762
 B
14 (20.0%)
10(12.1%)
Tumor size (cm)
7.3 ± 2.1
7.9 ± 2.7
0.801
Vascular invasion
   
 Absent
37 (52.8%)
49(59.0%)
0.837
 Present
33(47.2%)
34(41.0%)
 
BMI
   
 Normal weight
55(78.6%)
45(54.2%)
0.032
 Overweight/obese
15(21.4%)
38(45.8%)
P values in bold indicate statistical significance between groups. AFP, alpha-fetoprotein; BMI, body mass index.

Perioperative data

The intraoperative and postoperative data of 153 patients with large HCC who underwent liver resection are shown in Table 2. In the young group, non-anatomical resection was used in 31 (44.3%) patients, and 39 patients (55.7%) patients had hemihepatectomy or extended hemihepatectomy. In the young group, the surgical resection margin was ≤1 cm in 34 (48.6%) patients compared to 39 (47%) patients in the older group. The time for hepatic resection was 188 ± 9 minutes in the young group compared to 193 ± 23 minutes in the older group. The volume of blood loss was 1,196 ± 638 ml in the young group with 36 (51.4%) patients losing <1,000 ml compared to 1,226 ± 768 in the older group with 39 (47%) patients losing <1,000 ml. In the young group, 32 (45.7%) patients had no blood transfusion, the length of hospital stay was 14 ± 5 days with no hospital death, and the overall postoperative complication rate was 23% (16 patients). In the older group, 30 (36.1%) patients had no blood transfusion, the length of hospital stay was 16 ± 7 days, and the overall postoperative complication rate was 22.9% (19 patients).
Table 2
Perioperative data
Variables
Mean ± SD or number (%) of patients
Young group (n = 70)
Older group (n = 83)
P value
Type of surgical resection
   
 Non-anatomical resection
31(44.3%)
36(43.4%)
0.756
 Hemihepatectomy/extended hemihepatectomy
39(55.7%)
47(56.6%)
Surgical resection margin (cm)
   
 ≤1
34(48.6%)
39(47%)
0.936
 >1
36(51.4%)
44(53%)
 
Operative time (minutes)
188 ± 9
193 ± 23
0.673
Time for inflow occlusion (minutes)
13 ± 11
15 ± 13
0.516
Blood loss (ml)
1,196 ± 638
1,226 ± 768
0.475
 <1,000
36 (51.4%)
39(47%)
0.561
 ≥1,000
34 (48.6%)
44(53%)
 
Blood transfusion (patients)
   
 With
38 (54.3%)
53(63.9%)
0.625
 Without
32(45.7%)
30(36.1%)
 
Hospital mortality
0
1(1.2%)
0.543
Complications
16 (23.0%)
19(22.9%)
0.928
Hospital stay (days)
14 ± 5
16 ± 7
0.376

Postoperative complications

There was no significant difference in the overall postoperative complication rate between the two groups (23% vs 22.9%, P = 0.928; Table 3). The common complications of the two groups were ascites, wound infection, pleural effusion, pulmonary infection, biliary fistula, liver failure and bleeding. The most common complication in the young group was bleeding (8.6%), and the most common complication in the older group was pulmonary infection (13.3%). Pulmonary infection showed a significant difference between the two groups (P = 0.041). The only postoperative death was caused by liver failure in the older group (Table 3).
Table 3
Postoperative complications
 
Number (%) of patients
 
Complications
Young group
Older group
P value
Overall
16 (23.0%)
19 (22.9%)
0.928
 Ascites
2 (2.8%)
1 (1.2%)
0.326
 Wound infection
2(2.8%)
2(2.4%)
0.657
 Pleural effusion
1(1.4%)
1(1.2%)
0.536
 Pulmonary infection
1(1.4%)
11(13.3%)
0.041
 Biliary fistula
2 (2.8%)
1(1.2%)
0.326
 Liver failure
2(2.8%)
1(1.2%)*
0.326
 Bleeding
6(8.6%)
2(2.4%)
0.084
*Caused postoperative death. P values shown in bold indicate statistical significance between groups.

Long-term survival and prognostic factors of patients with large hepatocellular carcinoma after hepatectomy

The 1-, 3-, and 5-year overall survival rates in the young group were 93%, 79% and 47%. The 1-, 3-, and 5-year disease-free survival rates in the young group were 87%, 28% and 17%. The 1-, 3-, and 5-year overall survival rates in the older group were 85%, 75% and 40%. The 1-, 3-, and 5-year disease-free survival rates in the older group were 65%, 36% and 11%. Overall survival and disease-free survival in the young group and the older group were similar (P = 0.109 and P = 0.087, respectively; Figure 1).
Variables that might affect overall survival of young patients with large HCC after hepatic resection were also analyzed in this study (Table 4). Univariate analysis of the prognostic factorsfound that patients with liver cirrhosis (P = 0.045), vascular invasion (P = 0.017) and high Edmondson-Steiner grade (P = 0.036) had poorer overall survival than those without these variables. However, using multivariate analysis of the prognostic factors that predicted overall survival status, only presence of vascular invasion (P = 0.031) and high Edmondson-Steiner grade (P = 0.042) was significant (Table 4).
Table 4
Cox proportional hazard regression analyses for overall survival in young patients with large hepatocellular carcinoma after hepatectomy
Variables
n*
Univariateanalysis
Multivariate analysis
HR (95% CI)
P value
HR (95% CI)
P value
Gender
     
 Female
17
1
 
1
 
 Male
53
0.752(0.290-3.547)
0.548
0.721(0.309-3.176)
0.408
Hepatitis B status
     
 Positive
61
1
 
1
 
 Negative
9
0.963(0.243-4.416)
0.363
0.904(0.262-3.455)
0.789
AFP level (ng/mL)
     
 Negative
21
1
 
1
 
 Positive
49
1.006(0.561-1.012)
0.053
1.069(0.972-1.108)
0.129
Number of tumors
     
 Single
49
1
 
1
 
 Multiple
21
1.351(0.739-2.146)
0.053
1.683(0.460-2.373)
0.112
Liver cirrhosis
     
 Absent
38
1
 
1
 
 Present
32
1.114(1.058-2.934)
0.045
1.137(0.866-2.798)
0.207
Child-Pugh classification
     
 A
56
1
 
1
 
 B
14
1.237(0.762-2.387)
0.508
1.119(0.428-3.946)
0.623
Vascular invasion
     
 Absent
37
1
 
1
 
 Present
33
2.112(1.037-3.896)
0.017
2.233(1.010-4.232)
0.031
Edmondson-Steiner grade
     
 Low grade (I and II)
34
1
 
1
 
 High grade (III and IV)
36
1.560(1.087-3.331)
0.036
1.747(1.235-3.346)
0.042
Surgical resection margin
     
 ≤1 cm
34
1
 
1
 
 >1 cm
36
1.339(0.234-3.642)
0.743
1.366(0.356-2.956)
0.375
Blood loss (ml)
     
 <1,000
36
1
 
1
 
 ≥1,000
34
1.036(0.424-2.986)
0.117
1.352(0.374-3.463)
0.353
Blood transfusion (ml)
     
 Without
32
1
 
1
 
 With
38
1.008(0.532-1.787)
0.733
1.453(0.834-2.564)
0.656
Complications
     
 Absent
54
1
 
1
 
 Present
16
0.986(0.330-2.675)
0.559
0.824(0.363-2.863)
0.348
BMI
     
 Normal weight
55
1
 
1
 
 Overweight/obese
15
1.006(0.687-1.331)
0.309
1.250(0.909-1.671)
0.326
*Number of patients. P values shown in bold indicate statistical significance between groups. AFP, alpha-fetoprotein; BMI, body mass index; HR, hazard ratio.

Discussion

Young patients with large HCC, who are rare in USA and Europe, are not uncommon at diagnosis in China. Astudy showed that 30% of HCC patients were younger than 40 years old[8]; in our cohort this ratio reached 47%. The high liver cancer rates in young patients in China largely reflect the prevalence of chronic hepatitis B virus (HBV) infection[911]. In this study, the young group had more HBV-related HCC than the older group (87.2% vs66.3%, P = 0.031). This implied that HCC in most young patients was caused by HBV infection. This infection may even have happened in infancy and has caused liver cirrhosis after many years. HBV infection leads to HCC[1215]; therefore, regular examination of AFP and B ultrasound is very important for young patients with a history of hepatitis B infection. It is key for an early diagnosis and early operative treatment to improve the survival rate of young HCC patients. In the older group, there may be other factors involved. In the young group, 15 patients (21.4%) were overweight (BMI 25 to 29.9 kg/m2) or obese (BMI ≥30 kg/m2), compared to 38 patients (45.8%) in the older group (P = 0.032). It is implied that non-alcoholic fatty liver diseases, which are associated with obesity, may participate in the development of HCC, especially in older patients[1619]; therefore, we must pay more attention to the older patients who are overweight or obese.
Our study showed that hepatic resection for large HCC could be performed with an acceptable mortality rate and postoperative complication rates. The perioperative data were similar between two two groups, except that the older group had more pulmonary infection after hepatectomy. This implies that hepatectomy for young patients with large HCC is safe. We also found that the cumulative overall and disease-free survival curves after hepatectomy showed no statistical difference between the young and the older groups. This implies that hepatic resection for young patients with large HCC is efficacious.

Conclusion

In conclusion, the clinicopathologic characteristics and the outcome for young patients with large HCC after liver resection were similar to that of the older patients, except for differences in infection through HBV and BMI. Liver resection for young patients with large HCC is safe and efficacious and should be recommended.

Acknowledgements

Thanks to Mengchao Luo for Polishing language.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

XYL and JFX carried out the data collection and analysis, drafted the manuscript. Both authors read and approved the final manuscript.
Anhänge

Authors’ original submitted files for images

Below are the links to the authors’ original submitted files for images.
Literatur
1.
Zurück zum Zitat Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin. 2011, 61: 69-90. 10.3322/caac.20107.CrossRefPubMed Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin. 2011, 61: 69-90. 10.3322/caac.20107.CrossRefPubMed
2.
Zurück zum Zitat El-Serag HB: Hepatocellular carcinoma. N Engl J Med. 2011, 365: 1118-1127. 10.1056/NEJMra1001683.CrossRefPubMed El-Serag HB: Hepatocellular carcinoma. N Engl J Med. 2011, 365: 1118-1127. 10.1056/NEJMra1001683.CrossRefPubMed
3.
Zurück zum Zitat Villanueva A, Hoshida Y, Battiston C, Tovar V, Sia D, Alsinet C, Cornella H, Liberzon A, Kobayashi M, Kumada H, Thung SN, Bruix J, Newell P, April C, Fan JB, Roayaie S, Mazzaferro V, Schwartz ME, Llovet JM: Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma. Gastroenterology. 2011, 140: 1501-1512. 10.1053/j.gastro.2011.02.006.PubMedCentralCrossRefPubMed Villanueva A, Hoshida Y, Battiston C, Tovar V, Sia D, Alsinet C, Cornella H, Liberzon A, Kobayashi M, Kumada H, Thung SN, Bruix J, Newell P, April C, Fan JB, Roayaie S, Mazzaferro V, Schwartz ME, Llovet JM: Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma. Gastroenterology. 2011, 140: 1501-1512. 10.1053/j.gastro.2011.02.006.PubMedCentralCrossRefPubMed
4.
Zurück zum Zitat Mayer J, Auriol J, Muscari F: Worst prognosis of hypovascular hepatocellular carcinoma. J Hepatol. 2010, 52: 227-CrossRef Mayer J, Auriol J, Muscari F: Worst prognosis of hypovascular hepatocellular carcinoma. J Hepatol. 2010, 52: 227-CrossRef
5.
Zurück zum Zitat Huang J, Hernandez-Alejandro R, Croome KP, Zeng Y, Wu H, Chen Z: Hepatic resection for huge multinodular HCC with macrovascular invasion. J Surg Res. 2012, 178: 743-750. 10.1016/j.jss.2012.04.058.CrossRefPubMed Huang J, Hernandez-Alejandro R, Croome KP, Zeng Y, Wu H, Chen Z: Hepatic resection for huge multinodular HCC with macrovascular invasion. J Surg Res. 2012, 178: 743-750. 10.1016/j.jss.2012.04.058.CrossRefPubMed
6.
Zurück zum Zitat Ariizumi S, Kotera Y, Takahashi Y, Katagiri S, Yamamoto M: Impact of hepatectomy for huge solitary hepatocellular carcinoma: impact of hepatectomy for huge solitary hepatocellular carcinoma. J SurgOncol. 2013, 107 (4): 408-413. Ariizumi S, Kotera Y, Takahashi Y, Katagiri S, Yamamoto M: Impact of hepatectomy for huge solitary hepatocellular carcinoma: impact of hepatectomy for huge solitary hepatocellular carcinoma. J SurgOncol. 2013, 107 (4): 408-413.
7.
Zurück zum Zitat Yang LY, Xu JF, Ou DP, Wu W, Zeng ZJ: Hepatectomy for huge hepatocellular carcinoma: single institute’s experience. World J Surg. 2013, 37: 2189-2196. 10.1007/s00268-013-2095-5.CrossRefPubMed Yang LY, Xu JF, Ou DP, Wu W, Zeng ZJ: Hepatectomy for huge hepatocellular carcinoma: single institute’s experience. World J Surg. 2013, 37: 2189-2196. 10.1007/s00268-013-2095-5.CrossRefPubMed
8.
Zurück zum Zitat Wang HW, Hsieh TH, Huang SY, Chau GY, Tung CY, Su CW, Wu JC: Forfeited hepatogenesis program and increased embryonic stem cell traits in young hepatocellular carcinoma (HCC) comparing to elderly HCC. BMC Genomics. 2013, 14: 736-10.1186/1471-2164-14-736.PubMedCentralCrossRefPubMed Wang HW, Hsieh TH, Huang SY, Chau GY, Tung CY, Su CW, Wu JC: Forfeited hepatogenesis program and increased embryonic stem cell traits in young hepatocellular carcinoma (HCC) comparing to elderly HCC. BMC Genomics. 2013, 14: 736-10.1186/1471-2164-14-736.PubMedCentralCrossRefPubMed
9.
Zurück zum Zitat Motavaf M, Safari S, Saffari Jourshari M, Alavian SM: Hepatitis B virus-induced hepatocellular carcinoma: the role of the virus x protein. Acta Virol. 2013, 57: 389-396. 10.4149/av_2013_04_389.CrossRefPubMed Motavaf M, Safari S, Saffari Jourshari M, Alavian SM: Hepatitis B virus-induced hepatocellular carcinoma: the role of the virus x protein. Acta Virol. 2013, 57: 389-396. 10.4149/av_2013_04_389.CrossRefPubMed
10.
Zurück zum Zitat McMahon BJ: Chronic hepatitis B virus infection. Med Clin North Am. 2014, 98: 39-54. 10.1016/j.mcna.2013.08.004.CrossRefPubMed McMahon BJ: Chronic hepatitis B virus infection. Med Clin North Am. 2014, 98: 39-54. 10.1016/j.mcna.2013.08.004.CrossRefPubMed
11.
Zurück zum Zitat Keane MG, Pereira SP: Improving detection and treatment of liver cancer. Practitioner. 2013, 257: 21-26.PubMed Keane MG, Pereira SP: Improving detection and treatment of liver cancer. Practitioner. 2013, 257: 21-26.PubMed
12.
Zurück zum Zitat Araujo OC, Barros JJ, Do ÓKM, Nabuco LC, Luz CA, Perez RM, Niel C, Villela-Nogueira CA, Araujo NM: Genetic variability of hepatitis B and C viruses in Brazilian patients with and without hepatocellular carcinoma. J Med Virol. 2014, 86: 217-223. 10.1002/jmv.23837.CrossRefPubMed Araujo OC, Barros JJ, Do ÓKM, Nabuco LC, Luz CA, Perez RM, Niel C, Villela-Nogueira CA, Araujo NM: Genetic variability of hepatitis B and C viruses in Brazilian patients with and without hepatocellular carcinoma. J Med Virol. 2014, 86: 217-223. 10.1002/jmv.23837.CrossRefPubMed
13.
Zurück zum Zitat Sali S, Alavian SM, Foster GR, Keyvani H, Mehrnoosh L, Mohammadi N: Influencing factors on the outcome and prognosis of patients with HBV infection: seven years follow-up. Hepat Mon. 2013, 13: e8743-PubMedCentralPubMed Sali S, Alavian SM, Foster GR, Keyvani H, Mehrnoosh L, Mohammadi N: Influencing factors on the outcome and prognosis of patients with HBV infection: seven years follow-up. Hepat Mon. 2013, 13: e8743-PubMedCentralPubMed
14.
Zurück zum Zitat Yang Y, Jin L, He YL, Wang K, Ma XH, Wang J, Yan Z, Feng YL, Li YQ, Chen TY, Liu HL, Zhao YR: Hepatitis B virus infection in clustering of infection in families with unfavorable prognoses in northwest China. J Med Virol. 2013, 85: 1893-1899. 10.1002/jmv.23649.CrossRefPubMed Yang Y, Jin L, He YL, Wang K, Ma XH, Wang J, Yan Z, Feng YL, Li YQ, Chen TY, Liu HL, Zhao YR: Hepatitis B virus infection in clustering of infection in families with unfavorable prognoses in northwest China. J Med Virol. 2013, 85: 1893-1899. 10.1002/jmv.23649.CrossRefPubMed
15.
Zurück zum Zitat Iavarone M, Colombo M: HBV infection and hepatocellular carcinoma. Clin Liver Dis. 2013, 17: 375-397. 10.1016/j.cld.2013.05.002.CrossRefPubMed Iavarone M, Colombo M: HBV infection and hepatocellular carcinoma. Clin Liver Dis. 2013, 17: 375-397. 10.1016/j.cld.2013.05.002.CrossRefPubMed
16.
Zurück zum Zitat Michelotti GA, Machado MV, Diehl AM: NAFLD, NASH and liver cancer. Nat Rev Gastroenterol Hepatol. 2013, 10: 656-665. 10.1038/nrgastro.2013.183.CrossRefPubMed Michelotti GA, Machado MV, Diehl AM: NAFLD, NASH and liver cancer. Nat Rev Gastroenterol Hepatol. 2013, 10: 656-665. 10.1038/nrgastro.2013.183.CrossRefPubMed
17.
Zurück zum Zitat Rahman R, Hammoud GM, Almashhrawi AA, Ahmed KT, Ibdah JA: Primary hepatocellular carcinoma and metabolic syndrome: an update. World J Gastrointest Oncol. 2013, 5: 186-194.PubMedCentralCrossRefPubMed Rahman R, Hammoud GM, Almashhrawi AA, Ahmed KT, Ibdah JA: Primary hepatocellular carcinoma and metabolic syndrome: an update. World J Gastrointest Oncol. 2013, 5: 186-194.PubMedCentralCrossRefPubMed
18.
Zurück zum Zitat Vansaun MN, Mendonsa AM, Lee GD: Hepatocellular proliferation correlates with inflammatory cell and cytokine changes in a murine model of nonalcoholic fatty liver disease. PLoS One. 2013, 8: e73054-10.1371/journal.pone.0073054.PubMedCentralCrossRefPubMed Vansaun MN, Mendonsa AM, Lee GD: Hepatocellular proliferation correlates with inflammatory cell and cytokine changes in a murine model of nonalcoholic fatty liver disease. PLoS One. 2013, 8: e73054-10.1371/journal.pone.0073054.PubMedCentralCrossRefPubMed
19.
Zurück zum Zitat Tacke F, Yoneyama H: From NAFLD to NASH to fibrosis to HCC: role of dendritic cell populations in the liver. Hepatology. 2013, 58: 494-496. 10.1002/hep.26405.CrossRefPubMed Tacke F, Yoneyama H: From NAFLD to NASH to fibrosis to HCC: role of dendritic cell populations in the liver. Hepatology. 2013, 58: 494-496. 10.1002/hep.26405.CrossRefPubMed
Metadaten
Titel
Liver resection for young patients with large hepatocellular carcinoma: a single center experience from China
verfasst von
Xi-yu Liu
Jiang-feng Xu
Publikationsdatum
01.12.2014
Verlag
BioMed Central
Erschienen in
World Journal of Surgical Oncology / Ausgabe 1/2014
Elektronische ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-12-175

Weitere Artikel der Ausgabe 1/2014

World Journal of Surgical Oncology 1/2014 Zur Ausgabe

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Gegen postoperative Darmmotilitätsstörung: Erster Kaffee schon im Aufwachraum

30.04.2024 DCK 2024 Kongressbericht

Nach einer Operation kann es zu einer vorübergehenden Störung der Darmmotilität kommen, ohne dass es eine mechanische Ursache gibt. Auf eine postoperative Darmmotilitätsstörung weist besonders hin, wenn Nahrung oral nicht toleriert wird.

Welche Übungen helfen gegen Diastase recti abdominis?

30.04.2024 Schwangerenvorsorge Nachrichten

Die Autorinnen und Autoren einer aktuellen Studie aus Griechenland sind sich einig, dass Bewegungstherapie, einschließlich Übungen zur Stärkung der Bauchmuskulatur und zur Stabilisierung des Rumpfes, eine Diastase recti abdominis postpartum wirksam reduzieren kann. Doch vieles ist noch nicht eindeutig belegt.

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.